(Q40303266)

19 September 2017

1 reference

title

Acetylator phenotype and lupus erythematosus (English)

1 reference

19 September 2017

2

1 reference

19 September 2017

J P Uetrecht

1

1 reference

19 September 2017

1 March 1981

1 reference

Clinical Pharmacokinetics

19 September 2017

1 reference

19 September 2017

6

1 reference

19 September 2017

118-134

1 reference

19 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-198106020-00003

19 September 2017

0 references

cites work

Variations between individuals and populations in the acetylation of isoniazid and its significance for the treatment of pulmonary tuberculosis

1 reference

12 December 2020

A CLINICAL STUDY OF ISONIAZID INACTIVATION

1 reference

12 December 2020

Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: Comparison with procainamide

1 reference

12 December 2020

Immunologic findings in patients receiving methyldopa: a prospective study.

1 reference

12 December 2020

Experimental studies on the mechanism of induction of anti-nuclear antibodies by procainamide

1 reference

12 December 2020

Salazosulfapyridine-induced lupus erythematosus syndrome in ulcerative colitis (author's transl)

1 reference

12 December 2020

LUPUS DIATHESIS AND THE HYDRALAZINE SYNDROME

1 reference

12 December 2020

Comparison of the acetylation of procainamide and sulfadimidine in man

1 reference

12 December 2020

Antinuclear antibodies and lupus-like syndromes in children receiving anticonvulsants

1 reference

12 December 2020

SLE: idiopathic or drug-induced?

1 reference

12 December 2020

Immunologic and Coagulation Disorders in Chlorpromazine-Treated Patients

1 reference

12 December 2020

Antinuclear antibodies during procainamide treatment and drug acetylation.

1 reference

12 December 2020

Abnormal lymphocyte function is secondary to drug-induced autoimmunity

1 reference

12 December 2020

Less common side effects of methyldopa

1 reference

12 December 2020

Lymphocyte alteration by procainamide: relation to drug-induced lupus erythematosus syndrome

1 reference

12 December 2020

The rate of isoniazid inactivation in Finnish diabetic and non-diabetic patients

1 reference

12 December 2020

Acetylator phenotype in idiopathic systemic lupus erythematosus

1 reference

12 December 2020

Cutaneous vasculitis due to acebutolol

1 reference

12 December 2020

Cumulation of N-acetylprocainamide, an active metabolite of procainamide, in patients with impaired renal function

1 reference

12 December 2020

Hypocomplementemia in Procainamide-Associated Systemic Lupus Erythematosus

1 reference

12 December 2020

Antinative DNA antibodies as a reaction to pyrazole drugs

1 reference

12 December 2020

The polymorphic acetylation of dapsone in man

1 reference

12 December 2020

Studies on Serologic Abnormalities Induced by l-Dopa

1 reference

12 December 2020

The acetylator phenotype of patients with systemic lupus erythematosus

1 reference

12 December 2020

Hypocomplementemia in hydralazine-associated systemic lupus erythematosus

1 reference

12 December 2020

Quinidine-induced systemic lupus erythematosus

1 reference

12 December 2020

D-penicillamine and lupus erythematosuslike syndrome

1 reference

12 December 2020

Circulating immune complexes in sera from patients receiving procainamide

1 reference

12 December 2020

Normal distribution of acetylation phenotypes in systemic lupus erythematosus

1 reference

12 December 2020

Positive antinuclear factor tests with prazosin

1 reference

12 December 2020

Inactivation of isoniazid (INH) in Swedish tuberculous patients before and during treatment with para-aminosalicylic acid (PAS)

1 reference

12 December 2020

Quinidine-Induced Lupus Nephritis

1 reference

12 December 2020

Acetylation phenotype in rheumatoid arthritis

1 reference

12 December 2020

Evidence for the biotransformation of procainamide to a reactive metabolite

1 reference

12 December 2020

Circulating anticoagulant in the procainamide-induced lupus syndrome

1 reference

12 December 2020

Clinical Pharmacokinetics of Isoniazid

1 reference

12 December 2020

Untoward effects associated with practolol administration: oculomucocutaneous syndrome

1 reference

12 December 2020

Slow acetylation phenotype in systemic lupus erythematosus

1 reference

12 December 2020

Isoniazid and ethionamide serum levels and inactivation in Finnish subjects

1 reference

12 December 2020

Hydrallazine-induced lupus erythematosus-like syndrome in a patient of the rapid acetylator phenotype

1 reference

12 December 2020

Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis

1 reference

12 December 2020

Effect of coadministration of procainamide and isoniazid on each other's acetylation pathway

1 reference

12 December 2020

Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin.

1 reference

12 December 2020

Antibodies to Histones in Drug-Induced and Idiopathic Lupus Erythematosus

1 reference

12 December 2020

Procainamide-induced systemic lupus erythematosus. Renal involvement with deposition of immune complexes

1 reference

12 December 2020

Glomerulonephritis in procainamide induced lupus erythematosus: report of a case and review of the literature

1 reference

12 December 2020

Ethanol-induced increase in drug acetylation in man and isolated rat liver cells

1 reference

12 December 2020

Anticonvulsant-induced antinuclear antibodiesand lupus-like disease in children

1 reference

12 December 2020

Genetical and geographic studies on isoniazid inactivation.

1 reference

12 December 2020

Granulocytopenia, lupus-like syndrome, and other complications of propylthiouracil therapy

1 reference

12 December 2020

Hydrallazine in hypertension: is there a safe dose?

1 reference

12 December 2020

Practolol therapy associated with a systemic lupus erythematosus-like syndrome and an inhibitor to factor XIII

1 reference

12 December 2020

On the distribution and metabolism of azaperone (R 1929) in the rat and pig

1 reference

12 December 2020

Effects of long-term treatment with procaine amide. A prospective study with special regard to ANF and SLE in fast and slow acetylators

1 reference

12 December 2020

Lupus-type illness associated with labetalol

1 reference

12 December 2020

Polymorphic acetylation of procainamide in man

1 reference

12 December 2020

Genetic control of isoniazid metabolism in man

1 reference

12 December 2020

Systemic lupus erythematosus syndrome induced by practolol.

1 reference

12 December 2020

1 reference

12 December 2020

Genetic variations in the acetylation of isoniazid and other drugs

1 reference

12 December 2020

Acetylator phenotype in spontaneous SLE and rheumatoid arthritis

1 reference

12 December 2020

Lupus erythematosus in two patients after griseofulvin treatment of Trichophyton rubrum infection

1 reference

12 December 2020

Isoniazid induction of antinuclear antibodies. A prospective study

1 reference

12 December 2020

Development of antinuclear antibodies during acebutolol therapy

1 reference

12 December 2020

Chlorpromazine-induced systemic lupus erythematosus: case report and review of the literature

1 reference

12 December 2020

Procainamide-induced lupus erythematosus. Clinical and laboratory observations

1 reference

12 December 2020

Multiple N-acetyltransferases and drug metabolism. Tissue distribution, characterization and significance of mammalian N-acetyltransferase

1 reference

12 December 2020

Hydralazine therapy in hypertensive patients with idiopathic systemic lupus erythematosus

1 reference

12 December 2020

Case report. Propranolol-induced lupus syndrome?

1 reference

12 December 2020

The quantitative determination of isoniazid and para-aminosalicylic acid in body fluids

1 reference

12 December 2020

False-Positive FTA-ABS in Hydralazine-Induced Lupus

1 reference

12 December 2020

Enzymatic coupling of isoniazid to proteins.

1 reference

12 December 2020

Antinuclear antibody induced by procainamide. A prospective study

1 reference

12 December 2020

Lupus-like autoimmune syndrome after levodopa and benserazide

1 reference

12 December 2020

Hepatitis, arthritis and lupus cell phenomena caused by methyldopa.

1 reference

12 December 2020

Anti-DNA antibody in procainmide-induced lupus erythematosus. Determination using DNA fractionated by methylated albumin-kieselguhr chromatography

1 reference

12 December 2020

Antinuclear antibodies in patients on acebutolol

1 reference

12 December 2020

Lupus-like reaction to phenelzine

1 reference

12 December 2020

Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol)

1 reference

12 December 2020

An improved and simplified method of detecting the acetylator phenotype

1 reference

12 December 2020

Drug-induced antinuclear antibodies and lupus syndromes

1 reference

12 December 2020

Sulphasalazine-induced lupus syndrome in ulcerative colitis

1 reference

12 December 2020

Isoniazid acetylatlon rate and development of antinuclear antibodies upon isoniazid treatment

1 reference

12 December 2020

The Role of Enzymatic Coupling of Drugs to Proteins in Induction of Drug Specific Antibodies

1 reference

12 December 2020

Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility

1 reference

12 December 2020

Nitrofurantoin-induced chronic active hepatitis

1 reference

12 December 2020

Simultaneous analysis of dapsone and monoacetyldapsone employing high performance liquid chromatography: a rapid method for determination of acetylator phenotype

1 reference

12 December 2020

Diabetic dimorphism according to acetylator status

1 reference

12 December 2020

Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin

1 reference

12 December 2020

The frequency of isoniazid acetylase enzyme deficiency among Egyptians

1 reference

12 December 2020

Prevention of autoimmunity in experimental lupus erythematosus by soluble immune response suppressor

1 reference

12 December 2020

Drug-induced autoimmune disease

1 reference

12 December 2020

A comparison between the behavior of Eskimos and non-Eskimos to the administration of isoniazid

1 reference

12 December 2020

Lupus-like syndrome associated with pulmonary reaction to nitrofurantoin. Report of three cases

1 reference

12 December 2020

Kinetic discrimination of three sulfamethazine acetylation phenotypes

1 reference

12 December 2020

HUMAN ACETYLATION POLYMORPHISM

1 reference

12 December 2020

Phenotyping of South African black tuberculosis patients for inactivation of isoniazid

1 reference

12 December 2020

Relationship of acetyl transferase activity to antinuclear antibodies and toxic symptoms in hypertensive patients treated with hydralazine

1 reference

12 December 2020

Thrombocytopenia and L.E. cells after oxyphenbutazone

1 reference

12 December 2020

Acetylator phenotype in systemic lupus erythematosus

1 reference

12 December 2020

Antibodies to Nuclear Antigens in Patients Treated with Procainamide or Acetylprocainamide

1 reference

12 December 2020

Hydralazine-pyrimidine interactions may explain hydralazine-induced lupus erythematosus

1 reference

12 December 2020

Drug-induced systemic lupus erythematosus: A critical review

1 reference

12 December 2020

Nephrotic syndrome in procainamide induced lupus nephritis

1 reference

12 December 2020

Phospholipid monolayers and systemic lupus erythematosus

1 reference

12 December 2020

Systemic lupus erythematosus syndrome induced by pindolol

1 reference

12 December 2020

The effect of isoniazid and other drugs on the acetylation of procainamide in the intact rat

1 reference

12 December 2020

Immune Responses to Hydralazine and Nuclear Antigens in Hydralazine-Induced Lupus Erythematosus

1 reference

12 December 2020

Long-term use of procaine amide following acute myocardial infarction

1 reference

12 December 2020

Spontaneous systemic lupus erythematosus and acelylator phenotype

1 reference

12 December 2020

The effect of hydralazine and other drugs on the kinetics of procainamide acetylation by rat liver and kidney N-acetyltransferase

1 reference

12 December 2020

Drug acetylation phenotype unrelated to development of spontaneous systemic lupus erythematosus

1 reference

12 December 2020

Procainamide-induced systemic lupus erythematosus with hypocomplementemia

1 reference

12 December 2020

Rate of drug metabolism in obese volunteers before and during starvation and in azotemic patients

1 reference

12 December 2020

Disease and Acetylation Polymorphism

1 reference

12 December 2020

Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome

1 reference

12 December 2020

Acetylator phenotype and the clinical pharmacology of slow-release procainamide

1 reference

12 December 2020

Evaluation of the sulphapyridine acetylator phenotyping test in healthy subjects and in patients with cardiac and renal diseases

1 reference

12 December 2020

Drug metabolism in the elderly

1 reference

12 December 2020

In vitro acetylation of drugs by human blood cells

1 reference

12 December 2020

Clinicopathological study of a patient with procainamide-induced systemic lupus erythematosus

1 reference

12 December 2020

Cutaneous reactions to drugs, acetylation phenotype and HLA antigens in patients with and without systemic lupus erythematosus (SLE)

1 reference

12 December 2020

Antinuclear Antibodies and Cardiovascular Drugs

1 reference

12 December 2020

Drug induced lupus erythematodes (DILE). Minor tranquilizers and allopurinol as general inducers of the DILE syndrome?

1 reference

12 December 2020

10.2165/00003088-198106020-00003

Identifiers

DOI

1 reference

PubMed ID

7011656

Dimensions Publication ID

19 September 2017

0 references

1 reference

PubMed ID

7011656